Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Until approximately 2019, evidence-based medical therapy for HFpEF was limited compared to that of HFrEF, with diuresis as the only major treatment option
S., Lulla, D., Tay, T
Call or email our customer support team for help with shipping, billing, subscriptions, or general enquiries
This is especially important for people with type 2 diabetes, who often struggle with insulin resistance
CJC-1295 without DAC occupies the sweet spot: longer-acting than sermorelin (which degrades too fast for reliable clinical effect), shorter-acting than DAC (which sacrifices pulsatility), and considerably cheaper than tesamorelin (the only FDA-approved option in this class)
US$ 20.04
US$ 27.30
US$ 25.34
US$ 25.98
